Article first published online: 26 MAR 2009
© 2009 BJU INTERNATIONAL
Volume 103, Issue 8, page i, April 2009
How to Cite
FITZPATRICK, J. M. (2009), Editor's Comment. BJU International, 103: i. doi: 10.1111/j.1464-410X.2009.08396.x
- Issue published online: 26 MAR 2009
- Article first published online: 26 MAR 2009
Much has changed since I first became Editor in 2003. Back then, the BJUI was only published 12 times a year. Now we publish two issues a month, Essential Evidence for Urologists every two months and have a redesigned Web site (bjui.org), all of which give you even more opportunities to stay up to date on the latest urology research. These changes all reflect the Journal’s dedication to deliver to you, in a variety of formats, research and clinical material of the highest quality.
With this issue I would like to introduce you to the latest addition to what BJUI offers readers: the BJUI‘UroScan’, a news section that will appear in the second issue each month. This department is markedly different from the rest of the Journal’s content and represents a significant innovation to the traditional medical journal format. UroScan goes beyond delivering clinical information, to report on what is happening in the field of urology at large. Among some of the content you can look forward to in UroScan are interviews with the authors of key studies, international updates on practice and policy, information about new technology, treatments and clinical trials, and balanced discussions of critical issues in urology.
UroScan is the result of a collaboration between the Journal and our publisher Wiley-Blackwell (WB). WB Editorial Director Lisa Dionne and Editor Dawn Antoline worked with us to transform a general idea for a research highlights feature into Uroscan, a unique section that offers news and information tailored to the international urology community. I would like to thank all of the good folks at WB, and everyone else who had a hand in creating it, for their hard work and dedication to BJUI.
Turn to the next page to read our first edition of the BJUI UroScan. This month you will learn why the National Institute for Health and Clinical Excellence is being criticised for its analysis of four kidney cancer drugs, and whether patients with prostate cancer should lose weight before surgery, and much more. I hope you enjoy reading it as much as we have enjoyed creating it. I welcome your feedback on this new section. Please send any comments, suggestions, or recommendations of topics to highlight to me at firstname.lastname@example.org.
Lastly, I look forward to seeing you at the AUA meeting in Chicago on 25–30 April 2009.